Showing results (151-160 of 237) with videos related to

Sort By:
Pageof 24
Bone Marrow Transplantation|July 8, 2026
Fludarabine combined with treosulfan or total body irradiation as a conditioning therapy before allogeneic hematopoietic stem cell transplantation in acute lymphoblastic leukemia. A retrospective matched-pair analysis from the ALWP of the EBMTRyszard Swoboda, Myriam Labopin, Nicolaus Kröger, et al.
Bone Marrow Transplantation|December 20, 2024
Comparison of fludarabine/melphalan (FM140) with fludarabine/melphalan/BCNU (FBM110) in patients with relapsed/refractory AML undergoing allogeneic hematopoietic cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working PartyJesús Duque-Afonso, Jürgen Finke, Maud Ngoya, et al.
Haematologica|February 13, 2023
General condition and comorbidity of long-term survivors of adult acute lymphoblastic leukemiaNicola Gökbuget, Kristina Ihrig, Michael Stadler, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2014
Treatment of acute myeloid leukemia or myelodysplastic syndrome relapse after allogeneic stem cell transplantation with azacitidine and donor lymphocyte infusions--a retrospective multicenter analysis from the German Cooperative Transplant Study GroupThomas Schroeder, Elena Rachlis, Gesine Bug, et al.
Bone Marrow Transplantation|April 11, 2023
Impact of disease burden on clinical outcomes of AML patients receiving allogeneic hematopoietic cell transplantation: a study from the Acute Leukemia Working Party of the European Society for Blood and Marrow TransplantationIman Abou Dalle, Myriam Labopin, Nicolaus Kröger, et al.
Cancers|August 12, 2022
Clinical Post-SARS-CoV-2 Infection Scenarios in Vaccinated and Non-Vaccinated Cancer Patients in Three German Cancer Centers: A Retrospective AnalysisEvgenii Shumilov, Lena Aperdannier, Nicole Schmidt, et al.
Blood|January 20, 2018
Genomic CDKN2A/2B deletions in adult Ph<sup>+</sup> ALL are adverse despite allogeneic stem cell transplantationHeike Pfeifer, Katharina Raum, Sandra Markovic, et al.
Haematologica|March 5, 2026
Impact of FMS-like tyrosine kinase 3 inhibitor maintenance on post-transplant outcomes in acute myeloid leukemia with FMS-like tyrosine kinase 3 mutations: a real-world German registry analysis highlighting sorafenibRadwan Massoud, Sarah Flossdorf, Franziska Hanke, et al.
Bone Marrow Transplantation|April 8, 2026
Haploidentical transplantation with post-transplant cyclophosphamide is not inferior to 9/10-MUD transplantation with ATG in patients with myeloid malignanciesAndrea Gantner, Svenja Labuhn, Daniel Fürst, et al.
Haematologica|August 30, 2023
Allogeneic hematopoietic stem cell transplantation in patients aged 60-79 years in Germany (1998-2018): a registry studyJan Frederic Weller, Claudia Lengerke, Jürgen Finke, et al.
Pageof 24